Article Sidebar

PDF
Date Published: 07/12/2023
Abstract Views: 1176
Views PDF: 281
DOI: https://doi.org/10.51298/vmj.v532i1B.7512
Issue
Vol. 532 No. 1B (2023)
Section
Các bài báo
How to Cite
Nguyễn, T. H., & Nguyễn, T. T. U. (2023). EVAlUATION OF INTRATYMPANIC CORTICOSTEROID FOR TREATMENT IDIOPATHIC SUDDEN SENSORINEURAL HEARING LOSS TYPE E. Vietnam Medical Journal, 532(1B). https://doi.org/10.51298/vmj.v532i1B.7512

EVAlUATION OF INTRATYMPANIC CORTICOSTEROID FOR TREATMENT IDIOPATHIC SUDDEN SENSORINEURAL HEARING LOSS TYPE E

Thị Hồng Nguyễn1,, Thị Tố Uyên Nguyễn1
1 HMU

Main Article Content

Abstract

Idopathic sudden sensorineural hearing loss type E has a poor prognosis for recovery, and there is still controversy in treatment. Intratympanic corticosteroid is considered as an initial or combined treatment for SSNHL. We conducted a study on 62 patients diagnosed idopathic sudden sensorineural hearing loss type E and received intratympanic corticosteroid in treatment. Evaluate clinical characteristics, pure-tone audiometry and treatment outcomes. The mean post-treatment pure-tone average (PTA) threshold was 93.73 ± 23.6 dB. The rate of no improvement after treatment is the highest (82.3%), followed by slight improvement at 11.3%, partial recovery at 4.8%, and complete recovery at 1.6%. After intratympanic, patiens usually have no complications (83.9%).

Article Details

Keywords

Sudden sensorineural hearing loss, SSNHL, profound idiopathic sudden sensorineural hearing loss, intratympanic corticosteroid.

References

1. Danino J. Joachims, H.Z, Eliachar I, Dodoshin L, Ben – David, Y and Fradis. M (1984), “Tinnitus as a presenting factor in sudden deafness”, American Journal of Otolaryngology, 5, pp 394-396.
2. Martin H. et Martin Ch. (1982), “Les surdités brusques”, Encycl Med. Chir. Paris., Oto Rhino – Laryngologie, 20183, A10.
3. Sujana S. Chandrasekhar, MD et al., "Clinical Practice Guideline: Sudden Hearing Loss (Update),”, Otolaryngology– Head and Neck Surgery 2019, Vol. 161(1S) S1–S45
4. J.-B. Charrier and P. Tran Ba Huy (2005), “Surdités brusques idiopathiques,” Ann. d’Otolaryngologie Chir. Cervico-faciale, vol. 122, no. 1, pp. 3–17.
5. Siegel LG. The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am 1975;8:467–73.
6. Dai, Y., Lu, L., Hou, J., Yang, X., Li, H., Yang, Y., & She, W. (2017). Intratympanic methylprednisolone perfusion as a salvage treatment for profound idiopathic sudden sensorineural hearing loss. The Journal of Laryngology & Otology, 131(05), 404–410.
7. Eftekharian, A., & Amizadeh, M. (2015). Pulse steroid therapy in idiopathic sudden sensorineural hearing loss: A randomized controlled clinical trial. The Laryngoscope, 126(1), 150–155.
8. Liu, Y.-C., Chi, F.-H., Yang, T.-H., & Liu, T.-C. (2016). Assessment of complications due to intratympanic injections. World Journal of Otorhinolaryngology-Head and Neck Surgery, 2(1), 13–16.